Trastuzumab, in combination with carboplatin and docetaxel, does not prolong the QT interval of patients with HER2-positive metastatic or locally advanced inoperable solid tumors: results from a phase Ib study
Crossref DOI link: https://doi.org/10.1007/s00280-014-2603-9
Published Online: 2014-10-26
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Na
Redfern, Charles H.
Gordon, Michael
Eppler, Stephen
Lum, Bert L.
Trudeau, Caroline
License valid from 2014-10-26